alphaveGLAND₹2,950.00

Gland Pharma Ltd.

₹ CrorePeersDIVISLAB AUROPHARMA PPLPHARMA SYNGENE WOCKPHARMA ASTERDM COHANCE LALPATHLABMcap ₹48,604 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	3,541.3	3,750.5	4,052.0	4,052.0
+ Capital Work-in-Progress	237.9	150.6	342.2	342.2
+ Goodwill	242.3	248.2	293.9	293.9
+ Other Intangibles	112.2	105.7	108.6	108.6
+ Other Non-current Financial Assets	655.9	0.0	125.1	125.1
Non-current Financial Assets	655.9	0.0	125.1	125.1
+ Deferred Tax Assets	50.4	52.1	62.3	62.3
+ Other Non-current Assets	176.1	134.9	—	—
Total Non-current Assets	5,016.1	4,442.0	4,984.1	4,984.1
Current Assets
+ Inventories	1,655.2	1,685.2	1,743.9	1,743.9
+ Trade Receivables	1,558.7	1,516.5	1,891.4	1,891.4
+ Cash & Cash Equivalents	357.1	2,556.2	3,359.1	3,359.1
+ Other Bank Balances	1,482.3	0.0	0.0	0.0
+ Other Current Financial Assets	251.9	493.6	73.7	73.7
Current Financial Assets	3,650.1	4,566.4	5,324.2	5,324.2
+ Other Current Assets	339.9	531.4	458.7	458.7
Total Current Assets	5,645.2	6,782.9	7,526.8	7,526.8
Total Assets	10,661.2	11,224.9	12,510.8	12,510.8
Equity
+ Equity Share Capital	16.5	16.5	16.5	16.5
+ Other Equity / Reserves	8,707.4	9,134.3	10,341.5	10,341.5
Equity — Owners of Parent	8,723.8	9,150.7	10,358.0	10,358.0
Total Equity	8,723.8	9,150.7	10,358.0	10,358.0
Liabilities
+ Borrowings — Non-current	106.5	77.7	69.9	69.9
+ Other Non-current Financial Liab	34.7	29.5	23.3	23.3
Non-current Financial Liabilities	141.2	107.2	93.2	93.2
+ Provisions — Non-current	137.2	146.0	195.6	195.6
+ Deferred Tax Liabilities	220.1	214.8	214.4	214.4
+ Other Non-current Liabilities	40.5	41.4	41.2	41.2
Non-current Liabilities	539.0	509.3	544.5	544.5
+ Borrowings — Current	213.2	191.6	173.4	173.4
+ Trade Payables	862.7	820.4	833.9	833.9
+ Other Current Financial Liab	27.0	126.1	165.6	165.6
Current Financial Liabilities	1,102.9	1,138.0	1,172.9	1,172.9
+ Provisions — Current	58.9	50.9	54.1	54.1
+ Current Tax Liabilities	51.6	73.7	62.9	62.9
+ Other Current Liabilities	184.9	302.3	318.5	318.5
Current Liabilities	1,398.4	1,564.8	1,608.4	1,608.4
Total Liabilities	1,937.4	2,074.2	2,152.9	2,152.9
Total Equity & Liabilities	10,661.2	11,224.9	12,510.8	12,510.8
Trade Payables — MSME split
+ Dues to Other Creditors — Current	—	820.4	833.9	833.9

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.